Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

ABEO – Abeona Therapeutics Inc

Abeona Therapeutics Inc.
ABEO
$7.23
Name : Abeona Therapeutics Inc.
Sector : Healthcare
Industry: Biotechnology
Mark. Cap: $370,743,552.00
EPSttm : 0.64
finviz dynamic chart for ABEO
Abeona Therapeutics Inc.
$7.23
1.69%
$0.12

Float Short %

18.45

Margin Of Safety %

Put/Call OI Ratio

0.2

EPS Next Q Diff

-1.85

EPS Last/This Y

1.11

EPS This/Next Y

0.36

Price

7.23

Target Price

20.07

Analyst Recom

1

Performance Q

9.88

Relative Volume

0.94

Beta

1.65

Ticker: ABEO




21 items of 1

DateSymbolLastP/C OIP/C VolTotal OI
2025-07-25ABEO6.540.191.6837359
2025-07-28ABEO6.620.190.9237382
2025-07-29ABEO6.760.200.0637696
2025-07-30ABEO6.80.200.1437809
2025-07-31ABEO6.370.200.0137816
2025-08-01ABEO6.490.192.4437903
2025-08-04ABEO6.420.200.1638196
2025-08-05ABEO6.470.200.0038211
2025-08-06ABEO6.390.200.0038679
2025-08-07ABEO6.260.200.1838737
2025-08-08ABEO6.260.200.3338771
2025-08-11ABEO6.30.200.0838788
2025-08-12ABEO6.390.200.1739261
2025-08-13ABEO6.560.200.3339223
2025-08-14ABEO7.240.200.3039208
2025-08-15ABEO7.120.190.0339139
2025-08-18ABEO6.920.200.0638110
2025-08-19ABEO6.840.200.2038189
2025-08-20ABEO70.200.2338289
2025-08-21ABEO7.120.200.2438300
2025-08-22ABEO7.230.200.0038406
DateSymbolLastP/C OIP/C VolTotal OI
21 items Current Page1 of 1




21 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2025-07-25ABEO6.5310.4- -0.46
2025-07-28ABEO6.5910.4- -0.46
2025-07-29ABEO6.7510.4- -0.46
2025-07-30ABEO6.8010.4- -0.46
2025-07-31ABEO6.3710.4- -0.46
2025-08-01ABEO6.4910.4- -0.46
2025-08-04ABEO6.4210.4- -0.46
2025-08-05ABEO6.4710.4- -0.46
2025-08-06ABEO6.3910.4- -0.46
2025-08-07ABEO6.2710.4- -0.46
2025-08-08ABEO6.2610.4- -0.46
2025-08-11ABEO6.2910.4- -0.46
2025-08-12ABEO6.4010.4- -0.46
2025-08-13ABEO6.5610.4- -0.46
2025-08-14ABEO7.2310.4- -0.46
2025-08-15ABEO7.1210.4- -0.46
2025-08-18ABEO6.9110.4- -0.29
2025-08-19ABEO6.84204.3- -0.29
2025-08-20ABEO7.00204.3- -0.29
2025-08-21ABEO7.12204.3- -0.29
2025-08-22ABEO7.23-8.2- -0.44
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
21 items Current Page1 of 1




21 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2025-07-25ABEO-4.60-1.4118.65
2025-07-28ABEO-4.609.2718.65
2025-07-29ABEO-4.609.2718.65
2025-07-30ABEO-4.609.2718.65
2025-07-31ABEO-4.609.2718.65
2025-08-01ABEO-4.549.2718.65
2025-08-04ABEO-4.547.8318.65
2025-08-05ABEO-4.547.8318.65
2025-08-06ABEO-4.547.8318.65
2025-08-07ABEO-4.547.8318.65
2025-08-08ABEO-4.547.8318.65
2025-08-11ABEO-4.547.8418.65
2025-08-12ABEO-4.547.8418.51
2025-08-13ABEO-4.547.8418.51
2025-08-14ABEO-4.547.8418.51
2025-08-15ABEO-4.547.8418.51
2025-08-18ABEO-4.8419.6918.47
2025-08-19ABEO-4.8419.6918.47
2025-08-20ABEO-4.8419.6918.47
2025-08-21ABEO-4.8419.6918.45
2025-08-22ABEO-4.8619.6918.45
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
21 items Current Page1 of 1

Last Quarter Act. EPS

1.71

Avg. EPS Est. Current Quarter

-0.34

Avg. EPS Est. Next Quarter

-0.14

Insider Transactions

-4.86

Institutional Transactions

19.69

Beta

1.65

Average Sales Estimate Current Quarter

5

Average Sales Estimate Next Quarter

21

Fair Value

Quality Score

100

Growth Score

25

Sentiment Score

72

Actual DrawDown %

92.4

Max Drawdown 5-Year %

-97.3

Target Price

20.07

P/E

11.46

Forward P/E

42.95

PEG

P/S

926.86

P/B

2.27

P/Free Cash Flow

EPS

0.63

Average EPS Est. Cur. Y​

-0.44

EPS Next Y. (Est.)

-0.08

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

14310.5

Relative Volume

0.94

Return on Equity vs Sector %

10.3

Return on Equity vs Industry %

23.2

EPS 1 7Days Diff

EPS 1 30Days Diff

0.02

EBIT Estimation

Abeona Therapeutics Inc.
Sector: Healthcare
Industry: Biotechnology
Employees: 136
Abeona Therapeutics Inc., a clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening diseases. Its lead clinical program is pz-cel, an autologous, cell-based gene therapy for the treatment of patients with recessive dystrophic epidermolysis bullosa. The company also develops ABO-503 to treat X-linked retinoschisis; ABO-504 for the treatment of stargardt disease; and ABO-505 to treat autosomal dominant optic atrophy. In addition, it is developing AAV-based gene therapy through its AIM vector platform programs. The company was formerly known as PlasmaTech Biopharmaceuticals, Inc. and changed its name to Abeona Therapeutics Inc. in June 2015. Abeona Therapeutics Inc. was founded in 1974 and is headquartered in Cleveland, Ohio.
stock quote shares ABEO – Abeona Therapeutics Inc Stock Price stock today
news today ABEO – Abeona Therapeutics Inc stock forecast ,stock prediction 2023 2024 2025
marketwatch ABEO – Abeona Therapeutics Inc yahoo finance google finance
stock history ABEO – Abeona Therapeutics Inc invest stock market
stock prices ABEO premarket after hours
ticker ABEO fair value insiders trading